The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Durvalumab ± tremelimumab + platinum-etoposide in first-line extensive-stage SCLC (ES-SCLC): Updated results from the phase III CASPIAN study.
 
Luis G. Paz-Ares
Leadership - Altum Sequencing; European Medicines Agency (I); Genomica
Honoraria - Advanced Accelerator Applications; Amgen; AstraZeneca; Bayer; Blueprint Medicines; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Incyte; Ipsen; Lilly; Merck Serono; MSD; Novartis; Pfizer; PharmaMar; Roche/Genentech; Sanofi; Servier; Sysmex
Research Funding - AstraZeneca; Bristol-Myers Squibb
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; MSD; Pfizer; Roche; Takeda
Other Relationship - Amgen (I); Ipsen (I); Merck (I); Novartis (I); Pfizer (I); Roche; Roche (I); Sanofi (I); SERVIER (I)
 
Mikhail Dvorkin
No Relationships to Disclose
 
Yuanbin Chen
Consulting or Advisory Role - Array BioPharma; AstraZeneca; Bristol-Myers Squibb; Genentech; Pfizer; Takeda
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Guardant Health; Lilly; Merck; Novartis; Roche/Genentech; Takeda
Research Funding - Array BioPharma; AstraZeneca; Bristol-Myers Squibb; Helsinn Therapeutics; Ipsen; Roche/Genentech
Expert Testimony - AstraZeneca; Takeda
Travel, Accommodations, Expenses - AstraZeneca; Ipsen
 
Niels Reinmuth
Consulting or Advisory Role - Abbvie; AstraZeneca; Bristol-Myers Squibb; MSD; Pfizer; Roche; Takeda
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Pfizer; Roche; Takeda
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Roche; Takeda
 
Katsuyuki Hotta
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Chugai Pharma; Daiichi Sankyo; Kiowa Kirin; Kyorin; Lilly; MSD; Nippon Kayaku; Novartis; Ono Pharmaceutical; Pfizer; Taiho Pharmaceutical
Research Funding - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Chugai Pharma; Lilly
 
Dmytro Trukhin
No Relationships to Disclose
 
Galina Statsenko
No Relationships to Disclose
 
Maximilian Hochmair
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Roche; Takeda
 
Mustafa Özgüroğlu
Travel, Accommodations, Expenses - AstraZeneca
 
Jun Ho Ji
Speakers' Bureau - Boryung; Celltrion; Sanofi
Research Funding - AstraZeneca; Celltrion; Hyundai Pharm; LG Life Sciences; Lilly; Roche
 
Oleksandr Voitko
No Relationships to Disclose
 
Artem Poltoratskiy
No Relationships to Disclose
 
Francesco Verderame
Honoraria - Boehringer Mannheim Italy; Boehringer Mannheim Italy; MSD; MSD; MSD; MSD
Consulting or Advisory Role - Janssen; Janssen; Janssen; Janssen; Roche; Roche; Roche; Roche
Research Funding - AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Roche (Inst); Roche (Inst); Roche (Inst); Roche (Inst)
 
Libor Havel
No Relationships to Disclose
 
Igor Bondarenko
No Relationships to Disclose
 
Jon Armstrong
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Natalie Byrne
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Haiyi Jiang
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Jonathan Wade Goldman
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Celgene; Clovis Oncology; Genentech/Roche; Lilly; Trovagene; Vortex Biosciences
Speakers' Bureau - Merck
Research Funding - Abbvie; Array BioPharma; Astellas Pharma; Astex Pharmaceuticals; AstraZeneca/MedImmune; Bristol-Myers Squibb; Celgene; Clovis Oncology; Corvus Pharmaceuticals; Genentech/Roche; Lilly; Spectrum Pharmaceuticals; Threshold Pharmaceuticals